Nurix Therapeutics Inc (NRIX) Ownership

21.94 ↑0.90 (4.28%)
As of July 26, 2024, 3:59pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 4.6 million shares. Combined, the top 32 institutional holders of NRIX own 87.38% of the company with a total of 50.7 million shares.

In the latest ownership report on March 31st 2024, the top 32 institutional holders increased their combined ownership of NRIX by 1.8 million shares. 7 institutions bought 5,569,212 total additional shares and increased their ownership by an average of 164.73%. However 11 institutions sold 3,815,665 total shares and decreased their ownership by an average of 14.96%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc increased by a net total of 1,753,547 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc7.501%-1.364%4,580,414-63,3222024-03-31
Redmile Group, LLC7.341%57.364%4,483,0161,634,1892024-03-31
Baker Bros Advisors LP6.357%0.000%3,882,12502024-03-31
Deep Track Capital, LP4.909%0.000%2,997,83002024-03-31
State Street Corporation4.469%196.241%2,729,3361,808,0142024-03-31
ARK Investment Management LLC4.316%-17.517%2,635,338-559,6612024-03-31
Vanguard Group Inc4.232%-0.531%2,584,300-13,7972024-03-31
Morgan Stanley - Brokerage Accounts4.144%-19.274%2,530,799-604,2382024-03-31
T. Rowe Price Associates, Inc.3.596%-8.109%2,196,169-193,7972024-03-31
Deutsche Bank AG2.455%197.373%1,499,368995,1632024-03-31
Wasatch Advisors LP2.025%-55.023%1,236,753-1,512,9922024-03-31
Bain Capital Life Sciences Investors, LLC1.854%-37.879%1,132,397-690,4862024-03-31
Soleus Capital Management, L.P.1.826%679.720%1,115,000972,0002024-03-31
Geode Capital Management, LLC1.802%1.834%1,100,33519,8122024-03-31
Dimensional Fund Advisors, Inc.1.583%-3.359%966,453-33,5912024-03-31
Candriam Luxembourg S.C.A.1.461%-2.832%892,110-26,0002024-03-31
Affinity Asset Advisors, LLC1.327%17.409%810,253120,1412024-03-31
Pictet Asset Manangement SA1.190%-6.030%726,941-46,6472024-03-31
Charles Schwab Investment Management Inc1.052%3.197%642,19019,8932024-03-31
Goldman Sachs Group Inc0.807%-12.617%492,666-71,1342024-03-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc7.501%-1.364%4,580,414-63,3222024-03-31
Redmile Group, LLC7.341%57.364%4,483,0161,634,1892024-03-31
Baker Bros Advisors LP6.357%0.000%3,882,12502024-03-31
Deep Track Capital, LP4.909%0.000%2,997,83002024-03-31
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
State Street Corporation4.469%196.241%2,729,3361,808,0142024-03-31
ARK Investment Management LLC4.316%-17.517%2,635,338-559,6612024-03-31
Vanguard Group Inc4.232%-0.531%2,584,300-13,7972024-03-31
Morgan Stanley - Brokerage Accounts4.144%-19.274%2,530,799-604,2382024-03-31
T. Rowe Price Associates, Inc.3.596%-8.109%2,196,169-193,7972024-03-31
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Deutsche Bank AG2.455%197.373%1,499,368995,1632024-03-31
Wasatch Advisors LP2.025%-55.023%1,236,753-1,512,9922024-03-31
Boxer Capital LLC2.505%0.000%1,224,89202023-09-30
Bain Capital Life Sciences Investors, LLC1.854%-37.879%1,132,397-690,4862024-03-31
Soleus Capital Management, L.P.1.826%679.720%1,115,000972,0002024-03-31
Geode Capital Management, LLC1.802%1.834%1,100,33519,8122024-03-31
T. Rowe Price Investment Management,Inc.2.099%0.000%992,428992,4282022-09-30
Dimensional Fund Advisors, Inc.1.583%-3.359%966,453-33,5912024-03-31
Candriam Luxembourg S.C.A.1.461%-2.832%892,110-26,0002024-03-31
Affinity Asset Advisors, LLC1.327%17.409%810,253120,1412024-03-31
Pictet Asset Manangement SA1.190%-6.030%726,941-46,6472024-03-31
TCG Crossover Management, LLC1.175%0.000%717,654717,6542023-12-31
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Millennium Management LLC1.329%39.606%644,411182,8192023-06-30
Charles Schwab Investment Management Inc1.052%3.197%642,19019,8932024-03-31
Dafna Capital Management LLC1.139%0.000%556,69502023-09-30
Bank of America Corp1.118%-7.070%546,450-41,5752023-09-30
Nuveen Asset Management, LLC0.874%-19.509%533,865-129,3952023-12-31
Goldman Sachs Group Inc0.807%-12.617%492,666-71,1342024-03-31
Northern Trust Corp0.902%2.849%440,85212,2102023-09-30
FMR Inc0.859%-53.735%416,613-483,8752023-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2.6 million shares. Combined, the top 36 mutual fund holders of NRIX own 48.43% of the company with a total of 28.5 million shares.

In the latest ownership report on June 30th 2024, the top 36 fund holders increased their combined ownership of NRIX by 108 thousand shares. 1 funds bought 150,000 total additional shares and increased their ownership by an average of 25.99%. However 1 funds sold 41,670 total shares and decreased their ownership by an average of 2.93%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 108,330 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF2.143%-2.933%1,379,221-41,6702024-06-30
Belfius Equities Cure C Cap1.130%25.992%727,096150,0002024-06-30

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution4.056%-17.542%2,610,055-555,2742024-03-31
ARK Genomic Revolution ETF3.575%-0.458%2,300,624-10,5752024-06-28
Vanguard Total Stock Mkt Idx Inv2.955%2.058%1,901,52538,3462024-05-31
Vanguard Instl Ttl Stck Mkt Idx Tr3.240%29.436%1,571,546357,4002023-03-31
iShares Russell 2000 ETF2.286%33.049%1,471,460365,5062024-06-28
SPDR® S&P Biotech ETF2.143%-2.933%1,379,221-41,6702024-06-30
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
US Small-Cap Growth II Equity Comp1.773%-13.738%1,140,710-181,6732024-03-31
T. Rowe Price New Horizons1.773%-13.738%1,140,710-181,6732024-03-31
Wasatch Small Cap Growth Investor1.852%-2.514%898,101-23,1602023-09-30
Wasatch Ultra Growth1.355%-9.689%872,052-93,5582024-03-31
Vanguard Institutional Extnd Mkt Idx Tr1.276%0.778%821,2206,3432024-05-31
Belfius Equities Cure C Cap1.130%25.992%727,096150,0002024-06-30
Wasatch Small Cap Value1.430%29.273%702,910159,1682023-12-31
BlackRock Health Sciences Opps Inv A0.963%0.000%619,55702024-05-31
Vanguard Extended Market Index Investor1.278%-0.029%616,077-1812023-08-31
UBS: US Equity Small Cap Growth1.205%0.000%589,17602023-09-30
Xtrackers MSCI World Swap ETF 1C0.836%0.000%537,68002024-05-31
Candriam Global Equities Oncology0.835%-4.617%537,096-26,0002024-03-31
Nuveen Quant Small Cap Equity R60.813%28.817%523,100117,0202024-05-31
TIAA-CREF Quant Small-Cap Equity Instl1.026%20.000%501,61083,6002024-01-31
Xtrackers S&P Global Infra Swap ETF 1C0.752%0.000%483,68802023-12-31
Fidelity Small Cap Index0.735%-0.287%473,034-1,3632024-04-30
Fidelity® Small Cap Index0.940%1.146%456,1115,1682023-10-31
Candriam Eqs L Biotech C USD Cap0.679%23.132%437,10782,1152024-05-31
iShares Russell 2000 Value ETF0.706%-0.133%431,115-5722024-05-30
iShares Biotechnology ETF0.655%0.093%421,7423932024-06-28
Pictet-Biotech P USD0.628%-2.052%403,816-8,4602024-03-31
T. Rowe Price Small-Cap Value0.828%-30.260%390,408-169,4002022-09-30
BlackRock Health Sciences Term Trust0.601%0.000%387,01602024-05-31
Fidelity® Select Biotechnology0.756%0.000%366,64602023-08-31
Pictet-Global Megatrend Sel I USD0.741%5.347%364,18518,4832023-12-31
Wasatch Micro Cap0.717%27.338%352,48275,6732023-12-31
Nuveen Quant Small Cap Equity Instl0.501%-38.987%306,050-195,5602024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.482%0.000%294,51302024-04-30
Schwab Small-Cap Equity0.467%6.284%284,88916,8432024-03-31

Discussions

Please log in or register to share your thoughts.